Scientists described a system, called BEHAV3D, developed to study the dynamic interactions of immune cells and patient cancer organoids by means of imaging and transcriptomics.
[Nature Biotechnology]
Home Newsletters Human Immunology News Uncovering the Mode of Action of Engineered T Cells in Patient Cancer...
